84 patienter, hvoraf 39 havde fået 2 eller flere tidligere induktionsbehandlinger, og hvoraf 31 havde fået 1 tidligere induktionsbehandling, blev behandlet med 650 mg/ m2/ døgn nelarabin givet intravenøst over 1 time daglig i 5 på hinanden følgende dage gentaget hver 21. dag.
Eighty-four (84) patients, 39 of whom had received two or more prior induction regimens and 31 whom had received one prior induction regimen, were treated with 650 mg/ m2/ day of nelarabine administered intravenously over 1 hour daily for 5 consecutive days repeated every 21 days.